O'Brien Greene & Co. Inc Johnson & Johnson Transaction History

O'Brien Greene & Co. Inc

$303 Million
Q2 2024

A detailed history of O'Brien Greene & Co. Inc transactions in Johnson & Johnson stock. As of the latest transaction made, O'Brien Greene & Co. Inc holds 9,567 shares of JNJ stock, worth $1.59 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

9,567

Previous 8,770 9.09%

Holding current value

$1.59 Million

Previous $1.39 Million 0.79%

% of portfolio

0.46%

Previous 0.47%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$144.38 - $157.78 $115,070 - $125,750	797 Added 9.09%	9,567 $1.4 Million
Q2 2023 Aug 15, 2023	SELL	$154.35 - $166.11 $2.71 Million - $2.91 Million	-17,540 Reduced 66.67%	8,770 $1.45 Million
Q2 2023 Jul 20, 2023	BUY	$154.35 - $166.11 $2.71 Million - $2.91 Million	17,540 Added 200.0%	26,310 $4.36 Million
Q4 2022 Feb 02, 2023	SELL	$160.2 - $179.79 $2.92 Million - $3.28 Million	-18,236 Reduced 67.53%	8,770 $1.55 Million
Q3 2022 Nov 09, 2022	BUY	$161.33 - $179.52 $2.9 Million - $3.23 Million	18,003 Added 199.97%	27,006 $4.41 Million
Q2 2022 Aug 11, 2022	SELL	$168.19 - $186.01 $43,393 - $47,990	-258 Reduced 2.79%	9,003 $1.6 Million
Q1 2022 May 18, 2022	SELL	$158.14 - $179.59 $80,967 - $91,950	-512 Reduced 5.24%	9,261 $1.64 Million
Q4 2021 Feb 08, 2022	SELL	$155.93 - $173.01 $58,785 - $65,224	-377 Reduced 3.71%	9,773 $1.67 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $4.3 Million - $4.78 Million	-26,628 Reduced 72.4%	10,150 $1.64 Million
Q2 2021 Aug 09, 2021	BUY	$159.48 - $171.07 $250,383 - $268,579	1,570 Added 4.46%	36,778 $6.06 Million
Q1 2021 May 12, 2021	BUY	$153.07 - $170.48 $111,128 - $123,768	726 Added 2.11%	35,208 $5.79 Million
Q4 2020 Feb 04, 2021	BUY	$137.11 - $157.38 $369,511 - $424,139	2,695 Added 8.48%	34,482 $5.43 Million
Q3 2020 Nov 09, 2020	SELL	$140.38 - $153.83 $27,233 - $29,843	-194 Reduced 0.61%	31,787 $4.73 Million
Q2 2020 Aug 10, 2020	SELL	$128.81 - $155.51 $30,656 - $37,011	-238 Reduced 0.74%	31,981 $4.5 Million
Q1 2020 May 07, 2020	SELL	$111.14 - $153.99 $13,336 - $18,478	-120 Reduced 0.37%	32,219 $4.22 Million
Q4 2019 Feb 05, 2020	SELL	$127.5 - $146.44 $233,325 - $267,985	-1,830 Reduced 5.36%	32,339 $4.72 Million
Q3 2019 Nov 07, 2019	SELL	$126.95 - $142.14 $210,737 - $235,952	-1,660 Reduced 4.63%	34,169 $4.42 Million
Q2 2019 Aug 21, 2019	SELL	$131.15 - $144.24 $37,640 - $41,396	-287 Reduced 0.79%	35,829 $4.99 Million
Q1 2019 Apr 29, 2019	SELL	$125.72 - $139.79 $8,171 - $9,086	-65 Reduced 0.18%	36,116 $5.05 Million
Q4 2018 Feb 27, 2019	BUY	$122.84 - $147.84 $4.44 Million - $5.35 Million	36,181 New	36,181 $4.67 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Brien Greene & Co. Inc, based on Form 13F filings with the SEC.

News

Stay updated on O'Brien Greene & Co. Inc with notifications on news.

Account

O'Brien Greene & Co. Inc Johnson & Johnson Transaction History